Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 814.00K | $ 902.00K | $ 754.00K | $ 2.10M | $ 1.22M |
Total Assets | $ 12.72M | $ 11.29M | $ 11.07M | $ 11.09M | $ 11.37M |
Total Debt | $ ― | $ 690.00K | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ -212.00K | $ ― | $ ― | $ ― |
Total Liabilities | $ 3.24M | $ 3.18M | $ 2.96M | $ 3.30M | $ 2.90M |
Stockholders Equity | $ 9.49M | $ 8.11M | $ 8.11M | $ 7.79M | $ 8.47M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |